Patents by Inventor Céline Deraeve

Céline Deraeve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polyquinoline derivatives and the therapeutic use thereof
    Patent number: 8324196
    Abstract: The invention relates to a method for chelating metal ion and/or dissolving amyloid aggregates, including chelating metal ions and/or dissolving amyloid aggregates with a compound of formula (I):
    Type: Grant
    Filed: July 16, 2012
    Date of Patent: December 4, 2012
    Assignees: Palumed S.A., Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Céline Deraeve, Marguerite Pitie, Christophe Boldron, Bernard Meunier
  • NOVEL POLYQUINOLINE DERIVATIVES AND THE THERAPEUTIC USE THEREOF
    Publication number: 20120277265
    Abstract: The invention relates to a method for chelating metal ion and/or dissolving amyloid aggregates, including chelating metal ions and/or dissolving amyloid aggregates with a compound of formula (I):
    Type: Application
    Filed: July 16, 2012
    Publication date: November 1, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.), PALUMED S.A.
    Inventors: Céline DERAEVE, Marguerite Pitie, Christophe Boldron, Bernard Meunier
  • Polyquinoline derivatives and therapeutic use thereof
    Patent number: 8247396
    Abstract: The invention relates to compounds of general formula (I), to the process for the preparation thereof and to the use thereof as a therapeutic agent.
    Type: Grant
    Filed: August 4, 2006
    Date of Patent: August 21, 2012
    Assignees: Palumed S.A., Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Celine Deraeve, Marguerite Pitie, Christophe Boldron, Bernard Meunier
  • NOVEL POLYQUINOLINE DERIVATIVES AND THERAPEUTIC USE THEREOF
    Publication number: 20090227626
    Abstract: The invention relates to compounds of general formula (I), to the process for the preparation thereof and to the use thereof as a therapeutic agent.
    Type: Application
    Filed: August 4, 2006
    Publication date: September 10, 2009
    Applicant: PALUMED S.A.
    Inventors: Céline Deraeve, Marguerite Pitie, Christophe Boldron, Bernard Meunier